News & Press Releases
Filter by:
Drug Cartels as Foreign Terrorists: AML Spotlight
April 1, 2025
Member Steve Ganis was quoted in a FinOps Report article about how President Trump’s decision to classify drug cartels as foreign terrorist organizations (FTOs) has alerted anti-money laundering compliance executives at US financial institutions doing business in Latin America, particularly over AML compliance.
Of Counsel Benjamin Zegarelli was quoted in 360Dx related to the future of oversight for laboratory-developed-test following a recent decision in the Eastern District of Texas that vacated the FDA's final rule on LDTs.
ESG Practice Co-chair Jennifer Rubin was quoted in a Forbes article focused on how companies should consider responding to President Trump's executive orders related to DEI.
Member Lauren Moldawer recently connected with AIS Health about a Florida pharmacy benefit manager (PBM) law, the Prescription Drug Reform Act (PDRA). The Act aims to lower drug costs by requiring PBMs to forward all manufacturer rebates to plan sponsors and prohibiting mandatory mail-order pharmacy use for enrollees, among other reforms.
Lawyers: First AI Fair Use Case May Prove to be Outlier
March 24, 2025
Special Counsel Joseph Rutkowski was quoted in a Virginia Lawyers Weekly article about a recent Delaware federal court decision that represents the first substantive application of copyright law and fair use doctrine to artificial intelligence. The case was brought by Thomson Reuters against Ross Intelligence, an AI-powered legal research search engine intended to compete with the plaintiff’s product, Westlaw.
Member Jeffrey Moerdler was quoted in a Broadband Breakfast article about a recent panel he participated in titled "Where and How Can We Meet the Demand for Data Centers." According to panelists, mid-market data center operators are finding notable growth opportunities serving enterprise AI demands. They also discussed the power constraints affecting mid-market operators.
